Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000204949 | SCV000260871 | pathogenic | Charcot-Marie-Tooth disease type 4A | 2022-12-12 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 220379). Disruption of this splice site has been observed in individuals with autosomal recessive Charcot-Marie-Tooth disease type 4A (PMID: 12566285). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This sequence change affects a donor splice site in intron 4 of the GDAP1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in GDAP1 are known to be pathogenic (PMID: 11743580). |
Molecular Genetics Laboratory, |
RCV000789161 | SCV001336397 | pathogenic | Charcot-Marie-Tooth disease | criteria provided, single submitter | clinical testing | ||
MGZ Medical Genetics Center | RCV002288831 | SCV002578966 | pathogenic | Charcot-Marie-Tooth disease axonal type 2K | 2022-03-22 | criteria provided, single submitter | clinical testing | |
OMIM | RCV001839450 | SCV000024590 | pathogenic | Charcot-Marie-Tooth disease recessive intermediate A | 2003-03-01 | no assertion criteria provided | literature only | |
Inherited Neuropathy Consortium | RCV000789161 | SCV000928513 | uncertain significance | Charcot-Marie-Tooth disease | no assertion criteria provided | literature only | ||
Clinical Genetics, |
RCV001795333 | SCV002034705 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001795333 | SCV002035296 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Inherited Neuropathy Consortium Ii, |
RCV002288831 | SCV004174649 | uncertain significance | Charcot-Marie-Tooth disease axonal type 2K | 2016-01-06 | no assertion criteria provided | literature only |